| Huang TS, Chan ST, Ho TL, Su JL. Lee FP |
------>authors3_c=None ------>paper_class1=1 ------>Impact_Factor=None ------>paper_class3=0 ------>paper_class2=1 ------>vol=14 ------>confirm_bywho=tzengcr ------>insert_bywho=fplee ------>Jurnal_Rank=None ------>authors4_c=None ------>comm_author= ------>patent_EDate=None ------>authors5_c=None ------>publish_day=None ------>paper_class2Letter=None ------>page2=51 ------>medlineContent= ------>unit=E0114 ------>insert_date=20000707 ------>iam=5 ------>update_date= ------>author=??? ------>change_event=5 ------>ISSN=None ------>authors_c=None ------>score=500 ------>journal_name=Clin Otolaryngol ------>paper_name=Hypaque and steroids in the treatment of sudden sensorineural hearing loss ------>confirm_date=20030425 ------>tch_id=083020 ------>pmid=2920456 ------>page1=45 ------>fullAbstract=While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons. ------>tmu_sno=None ------>sno=2130 ------>authors2=None ------>authors3=None ------>authors4=None ------>authors5=None ------>authors6=None ------>authors6_c=None ------>authors=Huang TS, Chan ST, Ho TL, Su JL. Lee FP ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c=None ------>publish_area=None ------>updateTitle=Hypaque and steroids in the treatment of sudden sensorineural hearing loss. ------>language=2 ------>check_flag= ------>submit_date= ------>country=None ------>no= ------>patent_SDate=None ------>update_bywho= ------>publish_year=1989 ------>submit_flag= ------>publish_month=None |